Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederpharmatimes.com
PharmaTimes: News RSS
Get the latest updates from PharmaTimes: News RSS directly as they happen.
Follow now 138 followers
Latest posts
Last updated 1 day ago
Amgen’s Tepezza granted marketing authorisation in the UK
1 day ago
Teprotumumab approved as first targeted treatment for thyroid eye disease
iOnctura starts randomised phase 1/2 trial in lung cancer treatment
1 day ago
Study explores whether PI3Kδ targeting could combat resistance
MHRA grants Promising Innovative Medicine designation to UCB’s DoxTM for TK2d
3 days ago
UCB’s developmental treatment may be eligible for patient access
PharmaTimes Clinical Researcher of the Year – The Americas Awards
3 days ago
Demonstrate your skill and prowess by entering this year's awards!
Chiesi partners with Wirral Primary Care to improve COPD detection
4 days ago
New initiative aims to accelerate diagnosis and ease NHS pressures
Johnson & Johnson submits application for subcutaneous Rybrevan dosing
4 days ago
Company seeks approval for new schedules to improve patient convenience
Leqembi dosing proposal for Alzheimer’s treatment validated by MHRA
8 days ago
Application seeks reduced infusion frequency to support patient flexibility
Nice recommends first AI medical device for skin cancer diagnosis in the NHS
8 days ago
Approval marks milestone for AI use in frontline care
Lynozyfic receives EU approval for relapsed multiple myeloma treatment
10 days ago
New therapy offers hope for patients with limited option
Hundreds of genetic links to osteoarthritis unlocked
10 days ago
Study paves the way for personalised therapies for osteoarthritis sufferer
Takeda’s Adcetris receives positive opinion for Hodgkin lymphoma treatment
11 days ago
CHMP recommendation brings new hope for patients
Argenx receives positive CHMP opinion for CIDP treatment
11 days ago
VYVGART could be the first CIDP drug with a novel mechanism in...